Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

According to Reuters, Third Point takes stake in Cano Health (CANO) pushes for sale

  • March 10, 2022


StockCano Health, Inc.SymbolCANO
Date Announced03/09/2022Source Reuters
TypeCompany Seeking Strategic Alternatives

Hedge fund Third Point LLC is pushing Cano Health (CANO) to put itself up for sale because the senior-care facility operator’s stock price has tumbled since it went public with a blank check company.


August 22, 2022: Owl Creek Asset Management, on behalf of its affiliated investment funds, sent a letter to the Cano Health (CANO) Board of Directors strongly encouraging the Company to pursue strategic alternatives by engaging with investment bankers and other advisors to pursue a sale to a strategic buyer.

September 22, 2022: Humana (HUM), CVS (CVS), and other possible buyers are circling Cano Health (CANO) according to people familiar with the situation, as healthcare heavyweights scramble to snap up primary-care providers.

September 22, 2022: U.S. primary care provider Cano Health (CANO) is exploring a sale and working with advisors after receiving acquisition interest, according to people familiar with the matter.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.